Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-17

FDA Approved: SODIUM NITROPRUSSIDE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved the original ANDA for Sodium nitroprusside from Somerset Therapeutics, LLC, authorizing a generic IV vasodilator for use in hypertensive emergencie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium nitroprusside (sodium nitroprusside)

Snippet

ORIG AP for SODIUM NITROPRUSSIDE (SODIUM NITROPRUSSIDE)